Investment
Features
FeesSafety
Academy
More
Pluang+

CME launches Nasdaq CME Crypto Index Futures for easy trading of 7 major cryptocurrencies in one contract

Market News
09 Jun 2026
Crypto Briefing
View Source
Bullish
pluang ai news

CME Group introduced Nasdaq CME Crypto Index futures, a new product allowing institutional investors to trade a single contract representing a basket of seven major cryptocurrencies, including Bitcoin, Ethereum, and Solana. The index is heavily weighted toward Bitcoin at nearly 77%, with Ethereum and XRP following. The futures settle financially with no physical token delivery, available in standard and micro contract sizes to suit different investor needs. This offering provides a regulated, diversified crypto exposure option, differentiating CME from offshore exchanges and appealing to compliance-conscious institutional investors.

More News

Tron price steady near $0.33, trading in a narrow range with low volume signaling caution for buyers.

Tron price steady near $0.33, trading in a narrow range with low volume signaling caution for buyers.

As of August 11, 2026, Tron (TRX) trades around $0.3347, positioned in the middle of its 12-month range between a low of $0.2692 and a high of $0.3753. The price shows little momentum and moves sideways near its 50- and 200-day moving averages, indic...

Technical Signals
Neutral
4 hours ago
ICF International sees 24% stock upside with 2026 growth driven by energy, AI, and federal projects.

ICF International sees 24% stock upside with 2026 growth driven by energy, AI, and federal projects.

Analyst Barrington raised ICF International's price target to $110, suggesting a 24.45% upside from $88.39. The company expects 3% revenue growth and 5% non-GAAP EPS growth in 2026, fueled by energy, AI, and federal modernization efforts. Q2 2026 ear...

Analyst Insights
Bullish
4 hours ago
HSBC upgrades YPF to Buy on strong Q2 results and $51B LNG expansion plan

HSBC upgrades YPF to Buy on strong Q2 results and $51B LNG expansion plan

HSBC has upgraded YPF's rating to Buy following strong Q2 2026 results, including a 41.7% revenue increase to $6.57 billion and earnings per share of $3.07, surpassing estimates. YPF raised its 2026 adjusted EBITDA guidance to $8 billion and aims for...

Analyst Insights
Bullish
4 hours ago
Vivos Therapeutics beats Q2 EPS estimates but misses revenue, faces liquidity concerns.

Vivos Therapeutics beats Q2 EPS estimates but misses revenue, faces liquidity concerns.

Vivos Therapeutics reported Q2 2026 earnings per share of -$0.31, beating analyst expectations of -$0.42, but its revenue of $5.15 million fell short of the $5.63 million estimate. The company, focused on sleep apnea treatments, sees growing patient ...

Company Fundamentals
Neutral
4 hours ago
Ether.fi shows rising fees and TVL, with token holders climbing but no Q3 buybacks yet.

Ether.fi shows rising fees and TVL, with token holders climbing but no Q3 buybacks yet.

Ether.fi's protocol activity is growing, evidenced by rising fees reaching $2.8 million weekly and total value locked (TVL) increasing to $3.532 billion. The number of token holders has also grown to 131,940, indicating sustained demand despite no bu...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App